Difference between revisions of "Karusheva 2019 Am J Clin Nutr"

From Bioblast
Jump to: navigation, search
(Created page with "{{Publication |title=Karusheva Y, Koessler T, Strassburger K, Markgraf D, Mastrototaro L, Jelenik T, Simon MC, Pesta D, Zaharia OP, Bódis K, Bärenz F, Schmoll D, Wolkersdorf...")
 
Line 18: Line 18:
 
|keywords=Branched-chain amino acids, Diet, Gut microbiome, Insulin secretion, Insulin sensitivity, Mitochondrial function, Patients with type 2 diabetes
 
|keywords=Branched-chain amino acids, Diet, Gut microbiome, Insulin secretion, Insulin sensitivity, Mitochondrial function, Patients with type 2 diabetes
 
|editor=[[Plangger M]],
 
|editor=[[Plangger M]],
 +
|mipnetlab=DE Duesseldorf Roden M, DE Frankfurt Schmoll D
 
}}
 
}}
 
{{Labeling
 
{{Labeling

Revision as of 14:44, 4 November 2019

Publications in the MiPMap
Karusheva Y, Koessler T, Strassburger K, Markgraf D, Mastrototaro L, Jelenik T, Simon MC, Pesta D, Zaharia OP, Bódis K, Bärenz F, Schmoll D, Wolkersdorfer M, Tura A, Pacini G, Burkart V, Müssig K, Szendroedi J, Roden M (2019) Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial. Am J Clin Nutr 110:1098-107.

» PMID: 31667519 Open Access

Karusheva Y, Koessler T, Strassburger K, Markgraf D, Mastrototaro L, Jelenik T, Simon MC, Pesta D, Zaharia OP, Bodis K, Baerenz F, Schmoll D, Wolkersdorfer M, Tura A, Pacini G, Burkart V, Muessig K, Szendroedi J, Roden M (2019) Am J Clin Nutr

Abstract: Epidemiological studies have shown that increased circulating branched-chain amino acids (BCAAs) are associated with insulin resistance and type 2 diabetes (T2D). This may result from altered energy metabolism or dietary habits.

We hypothesized that a lower intake of BCAAs improves tissue-specific insulin sensitivity.

This randomized, placebo-controlled, double-blinded, crossover trial examined well-controlled T2D patients receiving isocaloric diets (protein: 1 g/kg body weight) for 4 wk. Protein requirements were covered by commercially available food supplemented ≤60% by an AA mixture either containing all AAs or lacking BCAAs. The dietary intervention ensured sufficient BCAA supply above the recommended minimum daily intake. The patients underwent the mixed meal tolerance test (MMT), hyperinsulinemic-euglycemic clamps (HECs), and skeletal muscle and white adipose tissue biopsies to assess insulin signaling.

After the BCAA- diet, BCAAs were reduced by 17% during fasting (P < 0.001), by 13% during HEC (P < 0.01), and by 62% during the MMT (P < 0.001). Under clamp conditions, whole-body and hepatic insulin sensitivity did not differ between diets. After the BCAA- diet, however, the oral glucose sensitivity index was 24% (P < 0.01) and circulating fibroblast-growth factor 21 was 21% higher (P < 0.05), whereas meal-derived insulin secretion was 28% lower (P < 0.05). Adipose tissue expression of the mechanistic target of rapamycin was 13% lower, whereas the mitochondrial respiratory control ratio was 1.7-fold higher (both P < 0.05). The fecal microbiome was enriched in Bacteroidetes but depleted of Firmicutes.

Short-term dietary reduction of BCAAs decreases postprandial insulin secretion and improves white adipose tissue metabolism and gut microbiome composition. Longer-term studies will be needed to evaluate the safety and metabolic efficacy in diabetes patients.This trial was registered at clinicaltrials.gov as NCT03261362.

Copyright © American Society for Nutrition 2019.

Keywords: Branched-chain amino acids, Diet, Gut microbiome, Insulin secretion, Insulin sensitivity, Mitochondrial function, Patients with type 2 diabetes Bioblast editor: Plangger M O2k-Network Lab: DE Duesseldorf Roden M, DE Frankfurt Schmoll D


Labels: MiParea: Respiration 





HRR: Oxygraph-2k 

Labels, 2019-11